Mumbai based Calyx Chemicals and Pharmaceuticals Pvt. Limited has informed the share market(BSE/NSE) that they have planning to enter capital markets with its initial public offer (IPO) of 6830000 shares of Rs 10 each. It also includes an employee reservation portion of 50000 equity shares. The company has filed a Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for the same. The premium to be decided via 100% book building process. The IPO price band has not been decided yet. Calyx Chemicals and Pharmaceuticals Limited is a manufacturer of active pharmaceutical ingredients and intermediates.
The company has not disclosed about the utilisation of funds from the proceeds.
The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Book Running Lead Managers to the Issue are PL Capital Markets Pvt Ltd, Yes Bank and Punjab National Bank
The company’s standalone net sales grew to Rs 321.80 crore in 2009-10 from Rs 235.01 crore in the previous year, while profit after tax rose to Rs 21.89 crore in 2009-10 from Rs 15.48 crore in 2008-09.
Stay tuned to BelltheBull Blog for more news on Calyx Chemicals IPO !Google+